| Zenopa Novartis licenses wet AMD drug from Ophthotech Novartis has signed a licensing and commercialisation agreement with Ophthotech for a new treatment for wet age-related macular degeneration (wet AMD). The deal gives Novartis the right to market the drug … Ophthotech, Novartis Team up on $1B Deal for Eye DrugXconomy Ophthotech may get over $1 billion from eye drug deal with NovartisReuters Ophthotech licenses experimental eye drug to NovartisBusiness Insider StreetInsider.com (subscription) all 65 news articles |
Source: Wet Macular Degeneration News From Google News
Zennie Abraham | Zennie Abraham or “Zennie62” is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.